Urology - urothelial cancer, Malmö
1 – 10 of 200
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
The potential association between degree of mammographic spiculation and prognosis
- Contribution to journal › Article
-
Mark
Emergency computed tomography in acute renal colic is essential for correct diagnosis and shortens time to treatment and stone-free status
- Contribution to journal › Article
-
Mark
Re : Joshua J. Meeks. Urothelial Cancer: What Is the Role of Expression-based Subtypes to Guide Neoadjuvant Therapy in Muscle-invasive Bladder Cancer? Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2025.11.014
(2026) In European Urology Focus
- Contribution to journal › Letter
-
Mark
Application of the International Bladder Cancer Group prediction model for recurrence-free survival on a national cohort of primary intermediate risk non-muscle invasive bladder cancer
- Contribution to journal › Article
-
Mark
The Swedish national guidelines on prostate cancer: recurrent, metastatic and castration resistant disease
(2026) In Scandinavian Journal of Urology
- Contribution to journal › Article
-
Mark
Healthcare Resource Utilisation in Patients with Upper Tract Urothelial Carcinoma : Healthcare
- Contribution to journal › Article
-
Mark
Complications and clinical outcomes of retroperitoneal lymph node dissection for testicular cancer in a centralized population-based cohort in Sweden : insights from SWENOTECA
- Contribution to journal › Article
-
Mark
Proliferation- and cytotoxic immune signatures identify chemotherapy-responsive bladder tumors in a molecular subtype dependent manner
- Contribution to journal › Article
-
Mark
CD44v6 is associated with tumor aggressiveness and chemoresistance in bladder cancer
- Contribution to journal › Article
-
Mark
First-line enfortumab vedotin plus pembrolizumab in locally advanced or metastatic urothelial carcinoma—commentary on patient-reported outcomes in EV-302
- Contribution to journal › Debate/Note/Editorial
